About Mark Ehlert
Form D filings for Stabilux Biosciences in 2024 list Mark Ehlert as director.
Mark Ehlert first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Mark Ehlert in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Mark Ehlert works with at each company, as listed on that company's latest Form D.
Stabilux Biosciences, Inc. · Form D, May 16, 2024
JL
Jonathan Leinonen
Executive officer and director
YY
Yoke Yap
President and director
MM
Michael Mortlock
Executive officer
ST
Steve Tokarz
Executive officer and director
JR
John Ransom
Director